Quality of medical care for persons with serious mental illness: a comprehensive review
EE McGinty, J Baller, ST Azrin, D Juliano-Bult… - Schizophrenia …, 2015 - Elsevier
Objectives Prior studies suggest variation in the quality of medical care for somatic
conditions such as cardiovascular disease and diabetes provided to persons with SMI, but to …
conditions such as cardiovascular disease and diabetes provided to persons with SMI, but to …
Association of statin use with peripheral neuropathy in the US population 40 years of age or older (美国40 岁及以上人群的他汀使用情况与周围神经病变的关系)
EF Tierney, DJ Thurman, GL Beckles… - Journal of …, 2013 - Wiley Online Library
摘要背景周围神经病变是一种严重的糖尿病并发症, 在某些情况下可导致下肢丧失功能甚至截肢
. 自从他汀类药物问世以来, 其使用日益增加. 最近的报告表明他汀类药物可以影响周围神经病变 …
. 自从他汀类药物问世以来, 其使用日益增加. 最近的报告表明他汀类药物可以影响周围神经病变 …
Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association
JL Fleg, DE Forman, K Berra, V Bittner, JA Blumenthal… - Circulation, 2013 - Am Heart Assoc
Over the decade since the original scientific statement was published, there has been an
explosion of randomized controlled trials (RCTs) addressing secondary prevention of …
explosion of randomized controlled trials (RCTs) addressing secondary prevention of …
Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory …
RJ Glynn, W Koenig, BG Nordestgaard… - Annals of internal …, 2010 - acpjournals.org
Background: Randomized data on statins for primary prevention in older persons are limited,
and the relative hazard of cardiovascular disease associated with an elevated cholesterol …
and the relative hazard of cardiovascular disease associated with an elevated cholesterol …
National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998–2010
Background—Previous studies have reported conflicting findings regarding how the
incidence of heart failure (HF) after acute myocardial infarction (AMI) has changed over time …
incidence of heart failure (HF) after acute myocardial infarction (AMI) has changed over time …
Persisting gender differences and attenuating age differences in cardiovascular drug use for prevention and treatment of coronary heart disease, 1998–2010
C Koopman, I Vaartjes, EM Heintjes… - European heart …, 2013 - academic.oup.com
Background Evidence on recent time trends in age–gender differences in cardiovascular
drug use is scarce. We studied time trends in age–gender-specific cardiovascular drug use …
drug use is scarce. We studied time trends in age–gender-specific cardiovascular drug use …
Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis
Objectives: We sought to assess the relationship between increasing use of cardiovascular
medications and trends in long-term prognosis after myocardial infarction (MI) in the elderly …
medications and trends in long-term prognosis after myocardial infarction (MI) in the elderly …
Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits
S Keyhani, JV Scobie, PL Hebert, MA McLaughlin - Hypertension, 2008 - Am Heart Assoc
The purpose of this study was to provide an analysis of gender-based disparities in
hypertension and cardiovascular disease care in ambulatory practices across the United …
hypertension and cardiovascular disease care in ambulatory practices across the United …
Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009–2017
Objective To estimate the extent of suboptimal statin use for the secondary prevention of
atherosclerotic cardiovascular disease (ASCVD) at different stages of the treatment pathway …
atherosclerotic cardiovascular disease (ASCVD) at different stages of the treatment pathway …
Role of disease risk scores in comparative effectiveness research with emerging therapies
Background Usefulness of propensity scores and regression models to balance potential
confounders at treatment initiation may be limited for newly introduced therapies with …
confounders at treatment initiation may be limited for newly introduced therapies with …